Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Dow Tumbles 150 Points; Procter & Gamble Shares Rise On Upbeat Earnings

Published 23/01/2024, 17:17
Updated 23/01/2024, 18:40
© Reuters.  Dow Tumbles 150 Points; Procter & Gamble Shares Rise On Upbeat Earnings

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday.

The Dow traded down 0.43% to 37,837.65 while the NASDAQ fell 0.01% to 15,358.79. The S&P 500 also fell, dropping, 0.03% to 4,849.05.

Check This Out: How To Earn $500 A Month From Nvidia Stock

Leading and Lagging Sectors

Consumer staples shares rose by 0.8% on Tuesday.

In trading on Tuesday, real estate shares fell by 0.7%.

Top Headline

Shares of Procter & Gamble Company (NYSE: PG) gained on Tuesday after the company posted upbeat earnings for its second quarter.

The company reported second-quarter FY24 sales growth of 3% year-over-year to $21.441 billion, marginally missing the consensus of $21.47 billion. Adjusted EPS of $1.84 beat the consensus of $1.70.

For FY24, the company said it expects core EPS of $6.37-$6.43 (prior view $6.25-$6.43) versus the $6.41 estimate.

Equities Trading UP

FaZe Holdings Inc.. (NASDAQ: FAZE) shares shot up 107% to $0.3201 after the company announced Rollbit will sponsor its Counter-Strike team.

Shares of Ensysce Biosciences, Inc. (NASDAQ: ENSC) got a boost, surging 36% to $1.5499. Ensysce Biosciences said that the FDA has granted Breakthrough Therapy Designation for PF614-MPAR.

Nuvve Holding Corp. (NASDAQ: NVVE) shares were also up, gaining 44% to $4.3004 after the company announced that it was awarded a $16 million project for Fresno Economic Opportunities Commission's 50-shuttle fleet.

Equities Trading DOWN

Vroom, Inc. (NASDAQ: VRM) shares dropped 39% to $0.3225 after the company announced it is discontinuing its operations and winding down its used vehicle dealership business.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Shares of Nutex Health Inc. (NASDAQ: NUTX) were down 25% to $0.14. Nutex Health announced pricing of $10.0 million registered direct offering of common stock and warrants.

Revelation Biosciences, Inc. (NASDAQ: REVB) was down, falling 25% to $0.3136. Revelation Biosciences announced a 1-for-30 reverse stock split effective Jan. 25, 2024.

Also Check This Out: 3 Minutes To Boost Your Earnings: 3 Stocks With Over 3% Dividend Yields In Tech And Telecom Sector From Wall Street's Most Accurate Analysts

Commodities

In commodity news, oil traded down 0.2% to $75.01 while gold traded up 0.1% at $2,025.00.

Silver traded up 0.7% to $22.46 on Tuesday while copper rose 0.9% to $3.7985.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.26%, London’s FTSE 100 rose 0.08% while Spain’s IBEX 35 Index fell 1.10% The German DAX fell 0.30% French CAC 40 declined 0.37% while Italy’s FTSE MIB Index fell 0.39%.

Public sector net borrowing, excluding public sector banks, in the United Kingdom shrank to £7.8 billion in December, compared to £16.2 billion in the year-ago month.

Asia Pacific Markets

Asian markets closed mixed on Tuesday, with Japan’s Nikkei 225 falling 0.08%, Hong Kong’s Hang Seng Index climbing 2.63% and China’s Shanghai Composite Index gaining 0.53%. India’s S&P BSE Sensex, meanwhile, fell 1.53%.

The Bank of Japan maintained its key short-term interest rate at -0.1% during its January meeting. Singapore’s annual inflation rate rose to 3.7% in December from November's reading of 3.6%.

Economics

The composite manufacturing index in the US Fifth District area declined to a reading of -15 in January, compared to December’s reading of -11.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Cramer Says Stay Away From This Bitcoin Miner: 'I Don't Trust It'

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.